Advances Draw Crowds to BiOS

The latest clinical and technical advances in microscopy, therapeutic lasers, molecular imaging, nanophotonics, biophotonics and biosensors are expected to draw more than 1400 participants to BiOS, the world's largest biomedical optics and imaging conference, Jan. 19-24 at the San Jose McEnery Convention Center.

BiOS, part of the SPIE Photonics West 2008 conference, provides attendees with the premier technical forum for learning about the latest advances and is a major impetus for launching new applications and technologies; patent citations indicate the importance of the research introduced in these conferences, according to SPIE.

The event attracts medical and optical physicists, biomedical and research clinicians, optical and instrument developers, equipment designers, physicians, bioengineers, cell physiologists, pharmacologists and cancer therapists, among others, to its 1200 presentations on clinical, translational and fundamental research and development in biomedical optics, more than 75 technical courses and professional development workshops, and 150-company international biomedical optics exhibition.

The Hot Topics presentations, a plenary event taking place Saturday, Jan. 19 from 7 to 9:30 p.m., are expected to draw a large number of attendees. The sessions include: Progress in Therapeutic Lasers, Imaging and Treatment of Cancer Using Gold Nanoparticles, Monitoring and Predicting Chemotherapy Using Diffuse Optics, Photoacoustic Microscopy and Computed Tomography, Real-time Quantitative Microscopy on the Nanometer Scale, Probing Pancreatic Disease Using Tissue Optical Spectroscopy, Multidimensional Fluorescence Imaging, Single-Molecule Superresolution Imaging and Trapping, and Spectroscopy for Diagnostics and Interstitial Photodynamic Treatment Control.

The many conferences offered during BiOS will present the latest applications and research in a broad range of biomedical optics and life sciences technical areas. Program tracks include subjects in the areas of photonic therapeutics and diagnostics; clinical technologies and systems; tissue optics, laser tissue engineering and tissue engineering; biomedical spectroscopy, microscopy and imaging; and nanophotonics and biophotonics.

The BiOS exhibition (Jan. 19-20) provides the ideal venue for interacting with the early adopters of the newest biomedical technologies, as well as a launch pad for new applications and technologies in diagnostics, therapeutics, and instrumentation. The 150-company exhibition coincides with the BiOS symposium, and for companies involved in biomedical optics, BiOS is the place to be and be seen, SPIE said.

For more information, visit: http://spie.org/x13196.xml